Evaluation of a new-formula shampoo containing 6% glycyrrhetinic acid complex for scalp seborrheic dermatitis: A pilot study

J Cosmet Dermatol. 2022 Aug;21(8):3423-3430. doi: 10.1111/jocd.14623. Epub 2021 Nov 18.

Abstract

Background: Scalp seborrheic dermatitis (SD) is a chronic inflammatory dermatosis associated with sebum imbalance and proliferation of Malassezia species. Various antifungal shampoos are commonly used for scalp SD.

Aims: Glycyrrhetinic acid is known to have antioxidative, anti-inflammatory, and anti-allergic effects. This study was designed to evaluate the effectiveness of a new-formula shampoo that contains glycyrrhetinic acid for the treatment of scalp SD.

Patients/methods: Thirty-four patients were enrolled and treated with the 6% glycyrrhetinic acid complex shampoo. Efficacy was assessed clinically with Dermatology Life Quality Index (DLQI) and Adherent Scalp Flaking Score (ASFS) by the same dermatologist at baseline, week 2, and week 5. Among the 24 subjects with the most significant clinical improvement, four common microorganisms from scalp samples were analyzed by quantitative polymerase chain reaction (qPCR) at baseline, and week 5.

Results: The DLQI and ASFS at week 2 and week 5 improved significantly relative to baseline. The bacteria profiles showed a significant increase of Cutibacterium acnes and a decrease of Staphylococcus epidermidis at week 5. The fungi profiles showed significant decreases of both Malassezia restricta and Malassezia globosa. The ratio of C. acne to S. epidermidis increased significantly from 0.93 at baseline to 1.55 at week 5. The ratio of M. restricta to M. globosa decreased from 5.02 at baseline to 1.00 at week 5.

Conclusions: The effectiveness of this new regimen was objectively demonstrated at the clinical and microbiological levels. This new formula may alleviate the bacterial and fungal dysbiosis in scalp SD.

Keywords: dysbiosis; glycyrrhetinic acid; scalp; seborrheic dermatitis.

MeSH terms

  • Bacteria
  • Dandruff* / drug therapy
  • Dermatitis, Seborrheic* / drug therapy
  • Dermatitis, Seborrheic* / microbiology
  • Glycyrrhetinic Acid* / therapeutic use
  • Humans
  • Malassezia*
  • Pilot Projects
  • Scalp / microbiology
  • Scalp Dermatoses* / microbiology

Substances

  • Glycyrrhetinic Acid

Grants and funding